Drug Database
Back to search

Netherlands· NL-3ed9d71d0d2b

YLPIO 80 mg/2,5 mg tabletten

A telmisartan und diuretika product containing indapamide 0-water + telmisartan, registered in Netherlands by PRO.MED.CS Praha a.s.. The same ATC class is registered in 13 of our 19 countries.

ATC C09DA07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedYLPIO 80 mg/2,5 mg tablettenATCC09DA07REGISTER NO.NL-3ed9d71d0d2bPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about indapamide 0-water + telmisartanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Telmisartan und diuretika is registered in 13 of 19 countries.

Countries holding a registration under ATC C09DA07 (telmisartan und diuretika), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search telmisartan und diuretika products by name

Telmisartan und diuretika · ATC C09DA07

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
INDAPAMIDE 0-WATER + TELMISARTAN
Manufacturer
PRO.MED.CS Praha a.s.
Country
Netherlands (NL)
ATC code
C09DA07
ATC class
Telmisartan und Diuretika
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    132781

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

80 interactions on record for telmisartan und diuretika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check telmisartan und diuretika against other medicinesHow interaction checks work

Telmisartan und diuretika · interactions on record

80 records

80 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Telmisartan und diuretika in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All telmisartan und diuretika products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Belgium · Ylpio
  • Bulgaria · Толмидуо
  • Cyprus · Tolmiduo
  • Czechia · Tedenomo, Telmisartan/Indapamid Pmcs
  • Germany · Telmicor-Inda, Telmiinda Apontis
  • Estonia · Tolurindo
  • Finland · Ylpio
  • Croatia · Tolurindo
  • Hungary · Tedenomo, Telmisartan/Indapamid Krka
  • Lithuania · Ilpio, Tolmiduo
  • Luxembourg · Ylpio
  • Latvia · Ilpio, Tolurindo
  • Poland · Tolurindo, Ylpio
  • Portugal · Tolurindo
  • Romania · Tolmiduo, Ylpio
  • Slovenia · Tolupind
  • Slovakia · Tolupind, Ylpio

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d703e911-d410-49a4-8698-e59ba0d164f3
GET /v1/drugs/d703e911-d410-49a4-8698-e59ba0d164f3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h132781_smpc.pdf",
  "strength": null,
  "atc_label": "Telmisartan And Diuretics",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132781",
  "excipients": [
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)",
    "NATRIUMHYDROXIDE (E 524)",
    "POVIDON K 25 (E 1201)"
  ],
  "substances": [
    "INDAPAMIDE 0-WATER",
    "TELMISARTAN"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132781.pdf",
  "authorised_at": "2025/07/28",
  "procedure_number": "CZ/H/1399/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "132781",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about telmisartan und diuretika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console